1 / 18

Attacking Mycobacterium tuberculosis with designer drugs

Attacking Mycobacterium tuberculosis with designer drugs . Chem 3000; Literature review. Shayne Rybchinski. March 26, 2009. Taken from: Davis, N., Decoding Genomes Of Tuberculosis Bacteria , accessed online at http://medicineworld.org/images/news-blogs/ on March 12, 2009.

derry
Télécharger la présentation

Attacking Mycobacterium tuberculosis with designer drugs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Attacking Mycobacterium tuberculosis with designer drugs Chem 3000; Literature review Shayne Rybchinski March 26, 2009 Taken from: Davis, N., Decoding Genomes Of Tuberculosis Bacteria , accessed online at http://medicineworld.org/images/news-blogs/ on March 12, 2009 Taken from: Casanas, B.,Tuberculosis -- Are You at Risk?, Accessed online athttp://a.abcnews.com/Health/Germs on March 12, 2009

  2. The Resurgence of an insidious disease: 1st line drugs: • Isoniazid • Rifampicin • Streptomycin • Ethambutol * 2nd line drugs: • Amikacin • Kanamycin • Capreomycin • Fluoroquinilone * Taken from: Fordyce, M., What is XDR-TB? Found online at www.clinicalcorrelations.org/?m=200702 on March 12, 2009

  3. Benzofuro[3,2-f][1]benzopyrans: A new class of antitubercular agents Synethesis and antimycobacterial evaluation of benzopyrananalgoes. Bioorganic and Medicinal Chemistry 15 (2007) 2177-2186 Bioorganic and Medicinal Chemistry 14 (2006) 5423-5428 Prado, P., Ledeit, H., Michel, S., Kock, M., Darbord, J. C., Cole, S. T., Tillequin, F., and Brodin, P. Prado, P., Janin Y. L., Saint-Joanis, B., Brodin, P., Michel, S., Koch, M., Cole, S. T., Tiellequin, F., and Bost, P. A new synthetic access to furo[3.2,-f]- chromene analogues of anantimycobacterial Bioorganic and Medicinal Chemistry 16 (2008) 8264-8272 Alvey L., Prado, S., Huteau, V., Saint-Joanis, B., Michel, S., Koch, M., Cole, S. T., Tillequin, F., and Janin, Y. L.,

  4. Drug Design Strategy: Chemical Design and Synthesis of Structural Analogues with Potential Acitivity Inspiration from Nature 3,3-dimethyl-3Hbenzofuro[3,2-ƒ][1]benzopyran DBB Usnic Acid Assay anti-mycobacterium activity In vivo assays Assay cyto-toxicity in mammalian cells Test selectivity by testing toxic activity against other bacteria Determination of specific activity

  5. Fused dimethylpyran rings in nature: Pyranoflavanone 5-methyllupinifoliol Benzopyranmethylripariochromene A Acridone alkaloid acrynycine

  6. Design Targets: OH, OCO X = H, OCOCH3 X = CH, N R = H, Me X = COH, CO,

  7. 3,3-dimethyl-3Hbenzofuro[3,2-f][1]benzopyran as a synthetic target: Δ 12 hrs OH 1.3-dichloro benzene Dimethyl- propargyl ether 3-chloro-3methyl-1-butyne + 3,3-dimethyl- 3Hbenzofuro-[3,2ƒ]- [1]benzopyran 2-hydroxydibenzofuran Prado, P., Ledeit, H., Michel, S., Kock, M., Darbord, J. C., Cole, S. T., Tillequin, F., and Brodin, P., Bioorganic and Medicinal Chemistry 14 (2006) 5423-5428

  8. Addition across the C-C π-bond: Pd-C H2 Ethanol OsO4 NMNO 1. Acetic Anhydride 2. H2O NNCdM Δ 2-butanone Prado, P., Ledeit, H., Michel, S., Kock, M., Darbord, J. C., Cole, S. T., Tillequin, F., and Brodin, P., Bioorganic and Medicinal Chemistry 14 (2006) 5423-5428

  9. Biological Activity; MIC99(μg/ml):

  10. Drug Design Strategy: Chemical Design and Synthesis of Structural Analogues with Potential Acitivity Inspiration from Nature Assay anti-mycobacterium activity In vivo assays Assay cyto-toxicity in mammalian cells Test selectivity by testing toxic activity against other bacteria Determination of specific activity

  11. Replacement of the furan ring of dibenzofuran: DBU CuCl2∙2H2O, inert atm. 1.2-dichloro- benzene, Δ CH2Cl2, k10 Ethanol NaBH3 1. CH2Cl2 2. AlCl3 Prado, P., Janin Y. L., Saint-Joanis, B., Brodin, P., Michel, S., Koch, M., Cole, S. T., Tiellequin, F., and Bost, P. , Bioorganic and Medicinal Chemistry 15 (2007) 2177-2186

  12. Biological Activity; MIC95 (μg/ml):

  13. Synthesis of 4-pyridal derivatives: Alvey L., Prado, S., Huteau, V., Saint-Joanis, B., Michel, S., Kock, M., Cole, S. T., Tillequin, F., and Janin, Y. L., Bioorganic and Medicinal Chemistry 16 (2008) 8264-8272

  14. Synthesis of 4-pyridal analogues: 1.3-dichloro benzene Δ, 12 hrs Inert atm. 2. DBU, CuCl2∙2H20 3. C4H5Cl EtOH H2O Na2S2O5

  15. Biological Activity; MIC95 (μg/ml):

  16. Summary and Conclusions: • Pyridine containing DBB analogues have excellent potential to develop new TB drugs and shorten time necessary for effective treatment. • Minor perturbations in structure can have a large impact on biological activity • The design of new drugs against TB remains a global imperative

  17. Claissen Rearrangement:

  18. Acronycines:

More Related